Projects

RNDr. Martina Takáčová, PhD.

National

Current
  • Study of inverse relationship between carbonic anhydrases CA IX and CA IV and its significance for tumor phenotype
    Program: VEGA
    Duration: 1. 1. 2024 – 31. 12. 2027
Finished
  • Development of unique TiMg composite dental implant
    Program: SRDA
    Duration: 1. 7. 2021 – 30. 6. 2025
  • Unraveling the mechanisms linking obesity and cancer progression: the interplay between adipocytes and cancer cells
    Program: VEGA
    Duration: 1. 1. 2020 – 31. 12. 2023
  • Immune response to SARS-CoV-2 infection and development of clinically relevant virological tests to improve the management of the COVID-19 pandemic
    Program: SRDA
    Duration: 16. 9. 2020 – 31. 12. 2021
  • Interaction of hypoxia with the signaling pathways implicated in differentiation, tumor progression and metastasis.
    Program: VEGA
    Duration: 1. 1. 2016 – 31. 12. 2019
  • Biochips and biosensors for glycorecognition, their development, prepararion and application in cancer research
    Program: SRDA
    Duration: 1. 7. 2015 – 30. 6. 2019
  • Elucidation of novel pro-metastatic functions of tumor-associated carbonic anhydrase IX and its cross-talk with pro-inflammatory response
    Program: SRDA
    Duration: 1. 7. 2015 – 30. 6. 2019
  • Regulation of carbonic anhydrase IX release and biological role of shed ectodomain in tumor cell-cell interactions
    Program: VEGA
    Duration: 1. 1. 2012 – 31. 12. 2015
  • Study of molecular mechanisms of carbonic anhydrase IX regulation and significance of its expression in colorectal cancer.
    Program: VEGA
    Duration: 1. 1. 2012 – 31. 12. 2015
  • Centre for Innovative Research of Antitumor and Antiviral Strategies
    Program: EU Structural Funds Research & Development
    Duration: 1. 5. 2011 – 31. 8. 2015
  • Identification of the molecular pathways driven by hypoxia-induced carbonic anhydrase IX in tumor cells
    Program: SRDA
    Duration: 1. 5. 2011 – 31. 10. 2014
  • Development of biopharmaceutics by modern biotechnology
    Program: EU Structural Funds Research & Development
    Duration: 1. 1. 2011 – 31. 12. 2013
  • Significance of the carbonic anhydrase IX as a non-invasive prognostic indicator and a molecular target in renal cell carcinoma
    Program: VEGA
    Duration: 1. 1. 2009 – 31. 12. 2011
Employees